DE1358716U - - Google Patents

Info

Publication number
DE1358716U
DE1358716U DENDAT1358716D DE1358716DU DE1358716U DE 1358716 U DE1358716 U DE 1358716U DE NDAT1358716 D DENDAT1358716 D DE NDAT1358716D DE 1358716D U DE1358716D U DE 1358716DU DE 1358716 U DE1358716 U DE 1358716U
Authority
DE
Germany
Prior art keywords
den
aiw
hyw
dead
yes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1358716D
Other languages
German (de)
English (en)
Publication of DE1358716U publication Critical patent/DE1358716U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DENDAT1358716D Active DE1358716U (enExample)

Publications (1)

Publication Number Publication Date
DE1358716U true DE1358716U (enExample)

Family

ID=672848

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1358716D Active DE1358716U (enExample)

Country Status (1)

Country Link
DE (1) DE1358716U (enExample)

Similar Documents

Publication Publication Date Title
NO179124B (no) Fremgangsmåte for fremstilling av et injiserbart, vandig, farmasöytisk preparat av 3-(hydroksymetyl)-5,5-difenylhydantoin-dinatriumfosfatester
Seals et al. Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location
Jerums et al. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis
DE102007048705A1 (de) Amorphe Formulierung
CH616932A5 (en) Process for the preparation of 2,4-diamino-5-benzylpyrimidines acting as potentiator for sulphonamides.
EP1425588B1 (de) Bestimmung der wirksamen parathormon-aktivität in einer probe
Fernando et al. Die euglykämische diabetische Ketoazidose (EDKA): Eine seltene, aber potenziell lebensbedrohliche Nebenwirkung durch SGLT2-Hemmer.
DE1494347U (enExample)
Karuppanan et al. Introduction and use of ELISA based technologies for the diagnosis and monitoring of foot-and-mouth disease in Malaysia
DE668741C (de) Verfahren zur Darstellung von Jod und freie oder veraetherte Oxygruppen enthaltenden2-Phenylchinolin-4-carbonsaeuren
DE746576C (de) Verfahren zur Darstellung von 2,4-Diamino-1,3,5-triazinen.
DE69003178T2 (de) Lyophilisiertes 6-(3-Dimethylaminopropionyl)-Forskolin-Präparat.
Hutchins Annotated list of Mississippi Rhopalocera
Ercan et al. Çalışan kalpte koroner baypas cerrahisi sırasında trimetazidine ve glikoz-insülin-potasyum kullanımının miyokard üzerine etkileri
DE1360283U (enExample)
McAdams The effect of temperature on the α‐adrenoceptor antagonist potency of indoramin and labetalol in the rat perfused mesenteric vascular bed
DE1505070U (enExample)
Hennies et al. Staatsverschuldung und intergenerative Lastenverschiebung. Ergänzende Überlegungen: Sind'Outright Monetary Transactions'(OMT) EUvertragskonform?
Schoch Tuberkulose—Screening
DE1626225U (de) Schlammsauger.
DE1401432U (enExample)
DE1504760U (enExample)
DE1533533U (enExample)
DE1622468U (de) Tierfalle.
Cecconi et al. 1959 Predictors of heart failure hospitalizations in hypertrophic cardiomyopathy